Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000721584 | SCV000852677 | uncertain significance | not provided | 2013-10-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001300607 | SCV001489753 | uncertain significance | RYR1-related disorder | 2022-07-05 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs759566652, gnomAD 0.004%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RYR1 protein function. ClinVar contains an entry for this variant (Variation ID: 590555). This variant has not been reported in the literature in individuals affected with RYR1-related conditions. This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 1759 of the RYR1 protein (p.Arg1759Trp). |
Revvity Omics, |
RCV000721584 | SCV003814351 | uncertain significance | not provided | 2019-03-07 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003999852 | SCV004836114 | uncertain significance | Malignant hyperthermia, susceptibility to, 1 | 2023-12-01 | criteria provided, single submitter | clinical testing |